Apogee Therapeutics Inc (APGE)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD ($) | |||
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -24.31M | -42.6M | -38.18M |
| Pre Tax Income | -20.84M | -31.74M | -32.09M |
| Net Income | -20.84M | -31.74M | -32.09M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 |
| EBIT | -24.31M | -42.6M | -38.18M |
| EBITDA | -24.31M | -42.6M | -38.18M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -93M |
| Pre Tax Income | -83.99M |
| Net Income | -83.99M |
| Preferred Dividends | 0 |
| Basic Earnings Per Share (EPS) | -1.657 |
| EBIT | -93M |
| EBITDA | -93M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
